Xcelerate, Inc. (OTC: XCRT) is comprised of a team of internationally renowned translational clinicians and engineers set to identify and acquire cutting-edge engineering technological advancements and intellectual property, most of which does not have immediately obvious applications to medical technology and clinical care. The Company acquires innovation at the engineering/patent level, marries it to the appropriate early-stage operational med tech company and applies it in a controlled clinical care setting which fosters engineering/clinical/business advancements under one umbrella. According to internal leadership, operating costs associated with high-level product development and commercialization, as well as the reliance on standard, ground-up research and development, are reduced — and even eliminated — through this approach. While the Company services several verticals, creating multiple revenue streams, its main source of revenue at this time is generating through licensing fees.
A Closer Look:
Xcelerate is comprised of an internationally renowned team of clinicians, thought leaders and engineers who have made it their mission to identify and acquire cutting-edge technologies that would improve the world of healthcare outside of the traditional clinical setting.
Xcelerate Inc. takes the power of medtech to a whole new level, reimagining the full potential of existing non-medical technologies by bridging the divide between quality healthcare and accessibility.
This early-stage startup uses artificial intelligence (AI), augmented reality (AR), the Internet of Things (IoT) and wearable technologies to assist patients who often live in remote villages or in areas where healthcare is simply out of reach. The company provides both patients and their doctors with a means of overcoming obstacles related to travel and distance and provides them with the simple tools and solutions necessary to conduct medical diagnostics testing – no matter the distance.
In January 2022, the company announced that it would acquire a 51% majority control of Afya Sasa Africa, LLC (ASA) and that it was committed to launching a series of programs that would change the way small villages would access healthcare altogether.
Dr. Dilan Elegalla, one of the Managers of this LLC, has relocated to Tanzania to establish a pilot program for the ASA System in that country. We are now excited to announce that, thanks to the efforts of Dr. Elegalla and his team, ASA now has verbal commitments to launch AfiyaSasa Tanzania as a pilot in 4 hospitals and likely in a fifth: KCMC (Kilimanjaro Christian Medical Centre). NSK Hospitals, ALMC (Arusha Lutheran Medical Center), and Haydon Lutheran Hospital. These four institutions represent a catchment area of approximately 20 million people. Once the pilot program is established and tested, they would continue with a rollout into the institution as well as their outreach clinics. A fifth hospital, Jakaya Kikwete Cardiac Institute, has expressed a strong interest in joining the pilot program. JKCI is a specialty hospital with countrywide reach (60 million Tanzanians plus regional patients).
At the current time the plan is to initiate the pilot program in one hospital and expand to additional facilities as the operational and technical issues are resolved. While no assurances can be provided, ASA expects to have a fully operational beta sites in at least four facilities by the end of Q2 2022 and expects to be revenue producing before the end of 2022.
Built on the same infrastructure that powers autonomous driving, Xcelerate’s AdviNOW virtual telehealth portal allows patients to connect with the outside medical community via compatible mobile devices. Many of these villages desperately lack the critical infrastructure they need to carry out quality medical care and treatment. There are very few, if any, medical professionals available, and it’s rather difficult to otherwise get to one.
The system is equipped with facial recognition and access to sensitive patient data stored onto a cloud server. Only returning patients can access this data via their cell phones, and only licensed physicians and medical personnel can conduct initial check-in and triage to determine the most appropriate medical course of action.
Physicians will interview their patients through individual, face-to-face telehealth visits.
Measurements are taken through connected medical devices and may include everything from a stethoscope to a thermometer to a pulse oximeter. Basic triage and vital records are also recorded in this manner. Family health histories and mental illness may also be noted. Medications can be prescribed. Diagnoses will be considered.
Tanzania To Be the First Country to Receive Technologies In Humanitarian Efforts
On March 14, 2022, Seeking Alpha broke down Xcelerate’s plans to launch a pilot program in Tanzania later this quarter.
Under the namesake of its now wholly-owned subsidiary, The AfiyaSasa Tanzania Project will be launched at 4 different hospitals across the country – each with its own range of services and telehealth capabilities, including:
- Kilimanjaro Christian Medical Centre (KCMC)
- NSK Hospitals (Hospital Network?)
- Arusha Lutheran Medical Center (ALMC)
- Haydon Lutheran Hospital
A possible program at a fifth hospital, Jakaya Kikwete Cardiac Institute, is in the works, as it has expressed a sincere interest in joining the pilot program.
The initial reach of the program would represent a total catchment area of approximately 20 million different patients – a significant number, considering Tanzania has close to 60.8 million residents, and many of whom are in desperate need of some sort of medical attention.
Once the pilot program has been established, tested and widely accepted by both patients and physicians, the company will continue rolling out similar projects at hospitals and outreach clinics throughout Tanzania and other parts of Africa.
Xcelerate foresees the success of its fully-operational beta sites by the end of Q2 2022, and that revenue will drastically increase before the end of 2022.
The Latest News from Xcelerate
MAULDIN, SC / ACCESSWIRE / April 14, 2022 / Xcelerate, Inc. (OTC Markets:XCRT) today announced it has retained SmallCapVoice.com Inc., an Austin, Texas-based investor relations and communications firm focused on socially responsible investments and companies.
AUSTIN, Texas, Apr 04, 2022 (GLOBE NEWSWIRE via COMTEX) — AUSTIN, Texas, April 04, 2022 (GLOBE NEWSWIRE) — SmallCapVoice.com Inc. (“SCV”) announces the availability of a new interview with Michael O’Shea, CEO of Xcelerate, Inc.
MAULDIN, SC / ACCESSWIRE / March 25, 2022 / Xcelerate, Inc. (OTC Markets:XCRT) recently announced that it signed a Membership Interest Purchase Agreement to acquire a 51% interest in AfiyaSasa Africa, LLC, (“ASA”) a start-up
MAULDIN, SC / ACCESSWIRE / March 17, 2022 / Xcelerate, Inc. (OTCMarkets:”XCRT) today announced that Thomas E. Mannle, Jr. has accepted an invitation to join its Advisory Board effective immediately. Thomas holds a B.S. from
MAULDIN, SC / ACCESSWIRE / March 14, 2022 / Xcelerate, Inc. (OTC PINK:XCRT) As recently announced, the Company has acquired majority control in AfiyaSasa Africa, LLC. (“ASA”), a medical technology and virtual health company that
AUSTIN, Texas, March 10, 2022 (GLOBE NEWSWIRE) — SmallCapVoice.com Inc. (“SCV”) announces the availability of a new interview with Michael O’Shea, CEO of Xcelerate, Inc. (OTC Pink: XCRT), to discuss how the Company is utilizing